ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $659,148 | -4.6% | 31,629 | +9.6% | 0.10% | -7.2% |
| Q2 2023 | $691,101 | +16.1% | 28,856 | -8.7% | 0.11% | -33.9% |
| Q1 2023 | $595,013 | +116.1% | 31,616 | +82.8% | 0.17% | +257.4% |
| Q4 2022 | $275,289 | -44.2% | 17,292 | -42.6% | 0.05% | -48.9% |
| Q3 2022 | $493,000 | +150.3% | 30,118 | +115.3% | 0.09% | +100.0% |
| Q2 2022 | $197,000 | -65.3% | 13,987 | -40.3% | 0.05% | -70.5% |
| Q1 2022 | $568,000 | +159.4% | 23,448 | +149.7% | 0.16% | +164.4% |
| Q4 2021 | $219,000 | -42.7% | 9,389 | +31.3% | 0.06% | -56.9% |
| Q4 2020 | $382,000 | -40.7% | 7,153 | -54.2% | 0.14% | -49.4% |
| Q3 2020 | $644,000 | +199.5% | 15,616 | +251.3% | 0.27% | +153.3% |
| Q2 2020 | $215,000 | +1691.7% | 4,445 | +519.1% | 0.11% | +94.5% |
| Q4 2018 | $12,000 | – | 718 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |